X 4 Pharmaceuticals Inc (XFOR)

X 4 Pharmaceuticals Inc Azioni (XFOR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	4.00%2.40	2.50	2.20	1.57	1.74
Cost Of Revenue	170.40%1.62	0.60	0.36	0.35	0.33
	2.40%15.08	15.45	18.52	-	-
Research and Development	2.40%15.08	15.45	18.52	-	-
Operating Income/Loss	19.28%-16.39	-20.31	-23.70	-27.51	-26.23
Nonoperating Income/Loss	263.08%0.24	0.07	-0.23	-2.34	0.53
Income/Loss From Continuing Operations Before Tax	20.19%-16.16	-20.24	-23.93	-29.85	-25.70
Income Tax Expense/Benefit	0.00	-	-	-0.03	0.04
	20.18%-16.16	-20.24	-23.93	-29.82	-25.74
Attributable To Parent	20.18%-16.16	-20.24	-23.93	-29.82	-25.74
Basic Average Shares	0.04%126.34	126.29	-	43.27	7.41
Diluted Average Shares	0.04%126.34	126.29	-	43.27	7.41
Basic Earnings Per Share	18.75%-0.13	-0.16	-	-0.69	-3.47
Diluted Earnings Per Share	18.75%-0.13	-0.16	-	-0.69	-3.47